Today: 4 March 2026
Browse Category

Stock Market 21 October 2025

NVIDIA Stock Set to Soar? Latest AI Boom & Stock Forecast Revealed

AI Gold Rush Sends Nvidia Soaring: NVDA Stock Near Highs as $100B OpenAI Deal, China Ban & New Chips Define 2025

Nvidia shares traded near $182 on Oct. 21, 2025, close to their record high of $195 set earlier this month. The company reported Q2 revenue of $46.7 billion, up 56% year-over-year, despite losing all China AI chip sales due to U.S. export bans. Nvidia announced major AI partnerships, including a $100 billion deal with OpenAI and a $5 billion stake in Intel. Wall Street remains bullish, with most analysts rating NVDA a “Buy.”
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock’s High-Stakes Surge: Record Sales, Price Cuts, and Musk’s $1 Trillion Gambit – What’s Next for TSLA?

Tesla stock traded near $445 on Oct. 21, close to its 52-week high, after the company reported record Q3 deliveries of 497,099 vehicles, beating estimates. Shares remain up about 80% for the year. Tesla recently launched cheaper Model 3 and Y versions, pressuring margins and prompting a 4% stock drop. Q3 earnings are due Oct. 22, with analysts expecting lower profits and muted outlook amid subsidy cuts and rising competition.
21 October 2025
Wall Street on Fire: Apple’s Record Rally Lifts Stocks as Earnings Season Heats Up

Wall Street on Fire: Apple’s Record Rally Lifts Stocks as Earnings Season Heats Up

Apple surged nearly 4% to a record close Monday after iPhone 17 sales outpaced last year’s launch, fueling a tech rally that sent the Nasdaq up 1.4%. General Motors jumped 13% on strong earnings, while Coca-Cola and Warner Bros. Discovery also gained. U.S. stock futures dipped early Tuesday as traders awaited major earnings and economic data. Treasury Secretary Bessent plans new U.S.-China talks this week.
Galaxy Digital (GLXY) Stock Soars on Massive Bitcoin Deal and Blowout Earnings

Galaxy Digital (GLXY) Stock Soars on Massive Bitcoin Deal and Blowout Earnings

Galaxy Digital stock jumped about 10% to $43 on October 21, 2025, after a 5% gain the previous day, reaching a one-year high. The surge followed blowout Q3 results: a $505 million profit, $28.4 billion in revenue, and a record 80,000 BTC sale. Rosenblatt Securities upgraded the stock and raised its price target to $44. Galaxy also secured a $460 million investment from a major asset manager.
Philip Morris (PM) Stock Surges as Forecast Raised Again – Smoke-Free Push Ignites Rally

Philip Morris (PM) Stock Surges as Forecast Raised Again – Smoke-Free Push Ignites Rally

Philip Morris International reported Q3 adjusted earnings of $2.24 per share, beating estimates and sending shares up 4–5% pre-market on October 21, 2025. The company raised its annual profit forecast for the third time this year to $7.46–$7.56 EPS. PMI increased its quarterly dividend to $1.47, yielding 3.7%. Wall Street maintains a “Moderate Buy” rating with an average $195 price target.
21 October 2025
Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug

Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug

Minerva Neurosciences shares jumped over 150% on October 21, 2025, after announcing a private placement to raise up to $200 million led by Vivo Capital. The cash will fund a Phase 3 trial and FDA resubmission for its schizophrenia drug roluperidone. Trading volume surged to 39.5 million shares, and the stock hit a new 52-week high near $6.80. Market cap rose from under $20 million to about $48 million.
Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?

Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?

Eos Energy announced a supply deal with MN8 Energy for up to 750 MWh of U.S.-made zinc batteries, with initial 200 MWh projects targeting data centers and manufacturing. Eos stock rose to $14.92 after the news, up 28% in 2025 and reaching 12-year highs. The company reported record Q2 revenue and a $19B project pipeline, but most analysts maintain a “Hold” rating with a $7.60 target.
Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone and TPG will acquire Hologic for $76 per share in cash plus a contingent value right worth up to $3, valuing the deal at $18.3 billion including debt. Hologic’s board approved the offer, which represents a 46% premium to its pre-deal price. Abu Dhabi Investment Authority and Singapore’s GIC will co-invest. Hologic shares rose about 7% on the news; the deal is expected to close in the first half of 2026.
Billionaire Blowup: NYC’s Catsimatidis Tells Rival to Quit – Pershing Square’s Ackman Admits He “Hates Wasting Money”

Billionaire Blowup: NYC’s Catsimatidis Tells Rival to Quit – Pershing Square’s Ackman Admits He “Hates Wasting Money”

John Catsimatidis urged Curtis Sliwa to exit the New York mayoral race, warning that a split vote could hand victory to Democratic Socialist Zohran Mamdani, who leads polls with about 52%. Sliwa refused to withdraw, accusing billionaires of meddling. Betting markets give Mamdani a 93% chance of winning. Analysts say Sliwa’s presence narrows Cuomo’s odds but does not close Mamdani’s lead.
21 October 2025
AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest Acquisition shareholders approved a merger with AMC Corporation on Sept 5, including $8 million in PIPE financing. Investors later allowed up to four one-month deadline extensions, each requiring a $55,000 deposit. About 1.513 million shares were redeemed, removing $18.2 million from the trust. ATMV shares spiked from $8.8 to $13 in pre-market trading on Oct 21 amid merger rumors.
Apple’s iPhone 17 BOOM: Sales Surge, Stock Soars Near $4T – What Analysts Say

Apple’s iPhone 17 BOOM: Sales Surge, Stock Soars Near $4T – What Analysts Say

Apple’s iPhone 17 lineup is selling 14% faster than last year’s model in the U.S. and China, with base model sales in China nearly doubling year-over-year, according to Counterpoint Research. Apple shares rose 4% to a record $263, lifting its market value to $3.9 trillion. Wall Street analysts raised price targets, though some warn expectations may be too high. Apple kept iPhone prices flat and launched new M5-chip devices without price hikes.
Lockheed Martin Stock Soars on Earnings Beat – “We’re an arm of the U.S. government,” analyst quips

Lockheed Martin Stock Soars on Earnings Beat – “We’re an arm of the U.S. government,” analyst quips

Lockheed Martin reported Q3 sales of $18.61 billion and earnings of $6.95 per share, beating analyst estimates. The company raised its 2025 profit outlook and reported a record $179 billion backlog, including major new contracts for F-35 jets, CH-53K helicopters, and Patriot missiles. Shares rose about 2.6% in premarket trading to $518.97.
UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Group shares closed at $364.48 on Oct. 21, up 2.2% on the day but still down about 30% for 2025 after plunging from an April peak near $630. The company will report Q3 earnings Oct. 28, with analysts expecting a sharp profit drop after UnitedHealth cut its full-year outlook due to surging medical costs. CEO Andrew Witty resigned in May, replaced by Stephen Hemsley.
21 October 2025
Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax reported Q3 adjusted earnings of $2.04 per share, beating estimates, with revenue at $1.55 billion. The company raised its full-year outlook and boosted its free cash flow target. Shares traded near $231 ahead of Oct. 21, up slightly after earnings but down 15% over the past year. Equifax also unveiled a new mortgage credit score pricing strategy to undercut FICO starting in 2026.
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health reported Q3 2025 adjusted earnings of $6.03 per share, beating analyst estimates by over $1. Revenue reached $50.1 billion, up 12% year-over-year and ahead of forecasts. Shares jumped as much as 7% pre-market on Oct. 21 before settling near the prior close. The company reaffirmed its full-year outlook and kept costs slightly below expectations.
Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher reported Q3 2025 adjusted earnings of $1.89 per share on $6.05 billion revenue, beating Wall Street estimates. Shares traded near $208, up 8% in a month but still down 20% year-over-year. The company kept its full-year EPS guidance at $7.70–$7.80, slightly below consensus, sending the stock down 1% pre-market. Most analysts rate DHR a “Buy,” with an average price target of $245.
GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

General Motors shares jumped 6–7% to over $61 on October 21 after Q3 earnings and revenue beat estimates and the company raised its 2025 profit outlook. Adjusted EPS reached $2.80, topping forecasts, while revenue hit $48.6 billion. GM also announced a slowdown in its EV rollout, taking a $1.59 billion charge tied to strategic changes. Wall Street sentiment turned more positive, with several analysts raising price targets.
3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M Stock Soars on Earnings Beat & Turnaround Progress – What Investors Need to Know

3M shares closed at $154.78 on Oct. 20, up 17.5% year-on-year, after Q3 earnings beat estimates and the company raised full-year guidance. The firm reported adjusted EPS of $2.19 on $6.3 billion revenue and now expects 2025 EPS of $7.95–$8.05. Legal liabilities from PFAS and earplug lawsuits persist, with a key PFAS trial set for late October. Analyst sentiment has improved, with price targets rising to as high as $185.
Go toTop